These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 15968276)
1. Transplantation of CD34+ selected peripheral blood to HLA-identical sibling patients with aplastic anaemia: results from a single institution. de la Rubia J; Cantero S; Sanz GF; Remigia MJ; Monteagudo E; Moscardó F; Martín G; Lorenzo I; Jiménez C; Martínez J; Montesinos P; Jarque I; Sanz MA Bone Marrow Transplant; 2005 Aug; 36(4):325-9. PubMed ID: 15968276 [TBL] [Abstract][Full Text] [Related]
2. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood. Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451 [TBL] [Abstract][Full Text] [Related]
3. Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia. Kumar R; Prem S; Mahapatra M; Seth T; Chowdhary DR; Mishra P; Pillai L; Narendra AM; Mehra NK; Saxena R; Choudhry VP Bone Marrow Transplant; 2006 Apr; 37(8):745-9. PubMed ID: 16518427 [TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin. Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700 [TBL] [Abstract][Full Text] [Related]
5. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT. Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteiza J; Jurado M; Oyonarte S; Sierra J; García-Conde J; Rozman C Bone Marrow Transplant; 1998 Sep; 22(6):519-25. PubMed ID: 9758337 [TBL] [Abstract][Full Text] [Related]
6. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies. Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507 [TBL] [Abstract][Full Text] [Related]
7. Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience. Gómez-Almaguer D; Vela-Ojeda J; Jaime-Pérez JC; Gutiérrez-Aguirre CH; Cantú-Rodríguez OG; Sobrevilla-Calvo P; Rivas-Vera S; Gómez-Rangel JD; Ruiz-Argüelles GJ Am J Hematol; 2006 Mar; 81(3):157-61. PubMed ID: 16493614 [TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose. Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278 [TBL] [Abstract][Full Text] [Related]
9. Audit of peripheral stem cell transplantation for aplastic anemia in multitransfused infected patients. Seth T; Kanga U; Sood P; Sharma V; Mishra P; Mahapatra M Transplant Proc; 2012 May; 44(4):922-4. PubMed ID: 22564586 [TBL] [Abstract][Full Text] [Related]
11. Outcome of allogeneic peripheral blood stem cell transplantation using matched sibling donors in patients with high-risk hematological diseases. Sohn SK; Kim DH; Kim JG; Sung WJ; Baek JH; Lee NY; Won DI; Suh JS; Lee KS; Lee KB Eur J Haematol; 2004 Jun; 72(6):430-6. PubMed ID: 15128422 [TBL] [Abstract][Full Text] [Related]
12. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. Bethge WA; Faul C; Bornhäuser M; Stuhler G; Beelen DW; Lang P; Stelljes M; Vogel W; Hägele M; Handgretinger R; Kanz L Blood Cells Mol Dis; 2008; 40(1):13-9. PubMed ID: 17869547 [TBL] [Abstract][Full Text] [Related]
13. Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD. Novitzky N; Thomas V; du Toit C; McDonald A Bone Marrow Transplant; 2009 May; 43(10):779-85. PubMed ID: 19079315 [TBL] [Abstract][Full Text] [Related]
14. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293 [TBL] [Abstract][Full Text] [Related]
15. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft-versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation. Abu-Ghosh A; Goldman S; Slone V; van de Ven C; Suen Y; Murphy L; Sender L; Cairo M Bone Marrow Transplant; 1999 Sep; 24(5):535-44. PubMed ID: 10482939 [TBL] [Abstract][Full Text] [Related]
16. Unrelated donor or partially matched related donor peripheral stem cell transplant with CD34+ selection and CD3+ addback for pediatric patients with leukemias. Bunin N; Aplenc R; Grupp S; Pierson G; Monos D Bone Marrow Transplant; 2006 Jan; 37(2):143-9. PubMed ID: 16284615 [TBL] [Abstract][Full Text] [Related]
17. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia. Lee JH; Choi SJ; Lee JH; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Lee KH Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661 [TBL] [Abstract][Full Text] [Related]
18. Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution. Sanz GF; Saavedra S; Jiménez C; Senent L; Cervera J; Planelles D; Bolufer P; Larrea L; Martín G; Martínez J; Jarque I; Moscardó F; Plumé G; Andreu R; de la Rubia J; Barragán E; Solves P; Soler MA; Sanz MA Bone Marrow Transplant; 2001 Apr; 27(7):693-701. PubMed ID: 11360108 [TBL] [Abstract][Full Text] [Related]
19. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen. Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960 [TBL] [Abstract][Full Text] [Related]
20. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients. Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]